SCHEMBL21688166

SCHEMBL21688166

N#Cc1ccc2c(c1)c1ccccc1n2-c1ccc(-c2ccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3C#N)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTGER4 P35408 2/20 0.34
TDP2 O95551 2/20 0.32
HDAC4 P56524 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PDPK1 O15530 1/20 0.31
RARG P13631 1/20 0.31
NR3C1 P04150 1/20 0.31
PGR P06401 1/20 0.31
HRH1 P35367 1/20 0.31
HTR6 P50406 1/20 0.31
G6PD P11413 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687990 0.97 ALDH1A1 (0.34) TDP2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21688034 0.94 KDM4E (0.33) KDM4EATML3MBTL1PTGER4ALDH1A1
SCHEMBL21688027 0.92 KDM4E (0.33) KDM4EATML3MBTL1PTGER4TDP2
SCHEMBL21688013 0.92 KDM4E (0.35) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL21687483 0.92 KDM4E (0.35) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL21688082 0.91 KDM4E (0.42) KDM4EATML3MBTL1HDAC4ALDH1A1
SCHEMBL21688035 0.91 NR3C1 (0.33) KDM4EATML3MBTL1PTGER4TDP2
SCHEMBL21687993 0.91 SMN1; SMN2 (0.34) TDP2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687621 0.90 ATM (0.41) KDM4EATML3MBTL1PTGER4TDP2
SCHEMBL21688016 0.90 KDM4E (0.34) KDM4EATML3MBTL1PTGER4TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.